Skip to main content
Department of Physical Medicine and Rehabilitation

Department of Physical Medicine and Rehabilitation

2013-2015 CoNEXTion Webinar and
Brainstorming Teleconference Schedule

Date

Time       

Topic

Content Presenter(s)

Monday, 
January 7th, 2013

4:00 PM (ET)

CoNEXTion Webinar: TBD

Contact rssandhu@ucdavis.edu for Access Code

TBD

Thursday,
January 10th, 2013

3:00 PM (ET)

Brainstorming Seminar:  Sleep Disorders

Contact rssandhu@ucdavis.edu for Access Code

Open discussion moderated by Beth Malow (Vanderbilt University)

Monday, 
February 4th, 2013

4:00 PM (ET)

CoNEXTion Webinar: TBD

Contact rssandhu@ucdavis.edu for Access Code

TBD

Monday, 
February 11th, 2013

4:00 PM
(ET)

Brainstorming Seminar: Normal Pressure Hydrocephalus

Contact rssandhu@ucdavis.edu for Access Code

Open discussion moderated by Joseph Quinn (Oregon Health and Science University)

Monday, 
March 4th, 2013

TBD

CoNEXTion Webinar: Cancelled

Contact rssandhu@ucdavis.edu for Access Code

TBD

Tuesday,

March 5th 2013

3:00PM (ET)

ZZ-3K3A-201: A multi-center, Phase 2, dose-escalation study to determine the safety and tolerability of 3K3A-APC in combination with tissue plasminogen activator (tPA) in moderately severe acute hemispheric ischemic stroke Contact rssandhu@ucdavis.edu for Access Code

Patrick Lyden (Cedars-Sinai Medical Center) 

March 2013

TBD

Brainstorming Seminar:  TBD

Open discussion moderated by TBD

Monday, 
April 1st, 2013

TBD

CANCELLED

TBD

April 2013

TBD

Brainstorming Seminar:  TBD

Open discussion moderated by TBD

Monday, 
May 6th, 2013

4:00 PM (ET)

CoNEXTion Webinar: Network and Ibudilast Progressive MS Study Update

Contact rssandhu@ucdavis.edu for Access Code

Drs. Robert Fox (Cleveland Clinic), Merit Cudkowicz (CCC) and Elizabeth McNeil (NINDS)

Thursday May 23rd, 2013

4:00 PM (ET)

Protocol Presentation Resubmission: Glyburide Advantage in Malignant Edema and Stroke (GAMES) Study

Contact rssandhu@ucdavis.edu for Access Code

Barney Stern (University of Maryland)

May  2013

TBD

Brainstorming Seminar:  TBD

Open discussion moderated by TBD

Monday, May 6, 2013

4:00 PM (ET)

“Network and Ibudilast Progressive MS Study Update”

Dr. Robert Fox (Cleveland Clinic)

Monday, 
June 3rd, 2013

TBD

Cancelled

TBD

Thursday,

June 20th, 2013

4:00 PM (ET)

Brain Repair for Infants with Traumatic Brain Injury using Epoetin alpha

Contact rssandhu@ucdavis.edu for Access Code

Shenandoah Robinson (Children’s Hospital) 

Friday,

June 21st, 2013

2:00 PM (ET)

Exploring the Efficacy and Tolerability of ITI-007 for Improving Sleep Maintenance and Behavioral Disturbances in Adolescents and Young Adults with Autism Spectrum Disorders (ASD)

Contact rssandhu@ucdavis.edu for Access Code

Kimberly Vanover (Intra-Cellular Therapies, Inc.)

June 2013

TBD

Brainstorming Seminar:  TBD

Open discussion moderated by TBD

Monday, 
July 1st, 2013

TBD

Cancelled

TBD

Tuesday,

July 2nd, 2013

12:00 PM (ET)

Brainstorming Seminar: Neurosarcoidosis

 

Open discussion moderated by Dr. David Clifford from Washington University

Monday, 
August 5th, 2013

TBD

CoNEXTion Webinar: TBD

TBD

August 2013

TBD

Brainstorming Seminar:  TBD

Open discussion moderated by TBD

Monday, September 9, 2013

TBD

Cancelled

TBD

Monday, October 7th, 2013

4:00 PM (ET)

“A Primer on the Regulatory and Market Path for Clinical Devices”

Kip Ludwig, PhD, from NINDS

Monday, November 4th, 2013

4:00 PM (ET)

“SMA Recruitment Strategies for the NN101 SMA Biomarkers Study”

Dr. Steve Kolb (OSU)

Friday, January 10th, 2014

2:00 PM (ET)

NN103 Rituximab in Myasthenia Gravis Study

Richard Nowak, MD, MS, (Yale University)

Tuesday, January 21st, 2014

2:30 PM (ET)

“How the NeuroNEXT CIRB Works: Site Expectations and Responsibilities”

Pearl O’Rourke, MD, Libby Hohmann, MD, and Emily Fogler, JD, from the NeuroNEXT Central IRB

Monday, January 27th, 2014

3:30 PM (ET)

Autoimmune Encephalitis

Elizabeth Wells and Adeline Vanderver from Children’s National Medical Center in Washington DC

February 28, 2014

4:00 PM (ET)

SRX246 for irritability and aggression in subjects with Huntington’s Disease

Dr. Michael Brownstein, MD

March 11, 2014

3:00 PM (ET)

SMA biomarkers and electrophysiology

W. David Arnold, MD

April 14, 2014

3:00 PM (ET)

NN104 CIRB process

Patrick Lyden, MD

May 27, 2014

4:00 PM (ET)

REPsy-PD: Rivastigmine for early psychosis in pts w/PD w/normal cognition, mild cognitive impairment and dementia

TBA

June 05, 2014

4:00 PM (ET)

Topical Intra-oral Ketoprofen 20% Organogel For The Prophylactic Treatment Of Migraine

Caren Behar MD FACP

Wednesday, July 23rd, 2014

2:00 PM (ET)

“CNS Accelerator Group: Attracting Small Pharma to NeuroNEXT”

John W. Henson, IV, MD, MBA, FAAN of Swedish Medical Center

Wednesday, July 28th, 2014

2:00 PM (ET)

“Night Wakings in Children with Autism: Which Treatments Show Promise?” Webinar

Beth Malow, MD, MS (Vanderbilt University)

September 29, 2014

1:00 PM (ET)

Randomized Double-Blind Placebo Controlled Parallel Group Crossover Study of the Potential of MSDC-0160 to Attenuate L-DOPA-Induced Dyskinesia (LID) in Patients with Parkinson’s Disease(PD)

Jerry Colca and Patrik Brundin

Wednesday, October 1st 2014

3:00 PM (ET)

“A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Crossover Study of the Potential of MSDC-0160 to Attenuate L-DOPA-Induced Dyskinesia (LID) in Patients with Parkinson’s Disease (PD)"

Jerry Colca, PhD and Patrik Brundin, MD, PhD

Wednesday, October 8th, 2014

1:00 PM (ET)

“Open-label, dose escalation safety study of d-methamphetamine in moderate to severe TBI patients”

David J. Poulsen, PhD, University of Montana

Tuesday, October 14th, 2014

2:00 PM (ET)

"A Trial to Investigate the Effectiveness of Testosterone Treatment in Men with Multiple Sclerosis"

Rhonda Voskuhl, MD, University of California Los Angeles

October 15, 2014

2:00 PM (ET)

Prospective Study of Cytochrome C Oxidase Activity as a Novel Biomarker In Subjects With Newly Diagnosed Primary Glioblastoma Multiforme (GBM)

Corinne E. Griguer, Ph.D.

Friday, November 14th, 2014

1:00 PM (ET)

NeuroNEXT Webinar: Network Update

Merit Cudkowicz, MD, MSc

Monday, December 1st, 2014

1:00 PM (ET)

NeuroNEXT CoNEXTion Webinar, “Diversity in Recruitment and Retention: NeuroNEXT and Beyond”

Dr. Nicte Mejia of Massachusetts General Hospital

December 18, 2014

Noon (ET)

IDEs/INDs for the Sponsor Investigator

John Marler, MD, NINDS

February 25, 2015

Noon

Poloxamer 188 NF for the treatment of respiratory and cardiac dysfunction in Duchenne muscular dystrophy

Thomas A. Collet, Ph.D.

February 27, 2015

4:00 PM (ET)

Topiramate as a Disease Altering Therapy for Cryptogenic Sensory Peripheral Neuropathy

A. Gordon Smith, MD

May 26, 2015

3:00 PM (ET)

Night Wakings in Children with Autism

Dr. Beth Malow

June 03, 2015

3;00 PM (ET)

NeuroNEXT network update

Merit Cudkowicz, MD, MSc

June 08, 2015

4:00 PM (ET)

StepWatchTM, a Putative Outcome Measure for CMT1A and CMT2A

Sean Ekins, Ph.D., D.Sc.,